Search

everythinglearnresearchcommunity

for

Search:↓

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

PRP injections may be an effective treatment for severe hair loss.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Platelet-rich plasma can help treat scarring hair loss caused by Discoid Lupus Erythematosus.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

JAK inhibitors are effective treatments for alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

The new gel effectively treats psoriasis with minimal side effects.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

Abrocitinib may effectively treat Lichen Planopilaris.

Injectable platelet-rich fibrin has improved healing and regeneration in various medical fields and can be more effective than previous treatments.